Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Session: Hodge Podge of ID Topics

523 - Impact of Sustained Virologic Response Achieved with Direct-Acting Antiviral Agents on Liver Fibrosis and Steatosis: A Systematic Review and Meta-Analysis

Saturday, October 19, 2024
12:30 PM – 12:35 PM US PT
Location: Halls JK - Arena 1

    Rapid Fire Presenter(s)

  • Stephanos Vassilopoulos, MD (he/him/his)

    Resident
    Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI
    Providence, RI, United States

    • Co-Author(s)

  • AV

    Athanasios Vassilopoulos, MD

    Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI
    Providence, Rhode Island, United States

  • AL

    Abby London, MD

    Department of Medicine, Warren Alpert Medical School of Brown University, Rhode Island Hospital
    Providence, Rhode Island, United States

  • MK

    Markos Kalligeros, MD

    Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI
    Providence, Rhode Island, United States

  • EM

    Eleftherios Mylonakis, MD, PhD

    Houston Methodist Hospital, Houston, TX
    Houston, Texas, United States

Disclosure(s):
Eleftherios Mylonakis, MD, PhD: BARDA: Grant/Research Support; Basilea: Advisor/Consultant; Chemic Labs/KODA Therapeutics: Grant/Research Support; Cidara: Grant/Research Support; Leidos Biomedical Research Inc./NCI: Grant/Research Support; NIH SciClone Pharmaceuticals: Grant/Research Support; NIH/NIAID: Grant/Research Support; NIH/NIGMS: Grant/Research Support; Pfizer: Grant/Research Support; Regeneron Pharmaceuticals, Inc.: Grant/Research Support